Table 3.
Local tumor response
| Before PSM, n (%) | cTACE+MWA | p | After PSM, n (%) | cTACE+MWA | p | |||
|---|---|---|---|---|---|---|---|---|
| Total | cTACE | Total | cTACE | |||||
| 1 month | ||||||||
| Patient, n | 90 | 58 | 32 | 42 | 21 | 21 | ||
| CR | 62 (68.9) | 32 (55.2) | 30 (93.8) | 0.001 | 33 (78.6) | 13 (61.9) | 20 (95.2) | 0.02 |
| PR | 13 (14.4) | 12 (20.7) | 1 (3.1) | 0.028 | 2 (4.8) | 1 (4.8) | 1 (4.8) | 1 |
| SD | 10 (11.1) | 9 (15.5) | 1 (3.1) | 0.09 | 5 (11.9) | 5 (23.8) | 0 (0) | 0.048 |
| PD | 5 (5.6) | 5 (8.6) | 0 (0) | 0.156 | 2 (4.8) | 2 (9.5) | 0 (0) | 0.488 |
| ORR | 75 (83.3) | 44 (75.9) | 31 (96.9) | 0.152 | 35 (83.3) | 14 (66.7) | 21 (100) | 0.009 |
| DCR | 85 (94.4) | 53 (91.4) | 32 (100) | 0.416 | 40 (95.2) | 19 (90.5) | 21 (100) | 0.488 |
| 6 months | ||||||||
| CR | 58 (64.4) | 31 (53.4) | 27 (84.4) | 0.007 | 31 (73.8) | 12 (57.1) | 19 (90.5) | 0.035 |
| PR | 5 (5.6) | 2 (3.4) | 3 (9.4) | 0.343 | 2 (4.8) | 1 (4.8) | 1 (4.8) | 1 |
| SD | 3 (3.3) | 3 (5.2) | 0 (0) | 0.55 | 1 (2.4) | 1 (4.8) | 0 (0) | 1 |
| PD | 24 (26.7) | 22 (37.9) | 2 (6.2) | 0.003 | 8 (19.0) | 7 (33.3) | 1 (4.8) | 0.045 |
| ORR | 63 (70.0) | 33 (56.9) | 30 (93.8) | 0.001 | 33 (78.6) | 13 (61.9) | 20 (95.2) | 0.02 |
| DCR | 66 (73.3) | 36 (62.1) | 30 (93.8) | 0.003 | 34 (81.0) | 14 (66.7) | 20 (95.2) | 0.045 |
Abbreviations: CR complete response, PR partial response, SD stable disease, PD progressive disease, ORR complete response + partial response, DCR ORR + stable disease